Foamix Pharmaceuticals Ltd (FOMX) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Foamix Pharmaceuticals Ltd   (FOMX)


Foamix Pharmaceuticals Ltd's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Foamix Pharmaceuticals Ltd's ROI in the fourth quarter of 2019?
Foamix Pharmaceuticals Ltd achieved a return on average invested assets (ROI) of 145.14 % in its fourth quarter of 2019, this is above FOMX's average return on investment of 112.92%.
Foamix Pharmaceuticals Ltd invested over the 12 months ending in its fourth quarter of 2019 $66 million

ROI has improved compared to 94.19% in the third quarter of 2019, due to net income growth.

Within the Consumer Non Cyclical sector Foamix Pharmaceuticals Ltd achieved the highest return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2019 quarter, so far to 26, from total ROI ranking in the third quarter of 2019 at 44.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Investment Change TTM -9.08 % 14.39 % 30.96 % -6.45 % -26.02 %
Y / Y Net Income Change TTM 28.34 % 67.2 % 134.01 % 635.72 % -
Investment (TTM) in Millions 52 68 62 80 93
Return On Investment (TTM) 145.14 % 94.19 % 74.8 % 78.4 % 102.82 %
FOMX's Overall Ranking # 26 # 44 # 71 # 60 # 44
Seq. Investment Change TTM -13.54 % -11.02 % 5.42 % 12.09 % 8.79 %
Seq. Net Income Change TTM 33.24 % 12.05 % 0.58 % -14.53 % 73.59 %
Net Income (TTM) in Millions 95 71 64 63 74

FOMX Company Profile >> Back to FOMX Roi Comparisons >> See Annual FOMX Return On Investment



Return On Investment FOMX's Ranking
Within: No.
Industry # 1
Sector # 1
Overall # 26

Return On Investment Statistics
High Average Low
156.91 %
112.92 %
74.8 %
(Jun 30 2018)   (Jun 30 2019)







Financial Statements
Foamix Pharmaceuticals Ltd's IV. Quarter Investments $ 52 Millions FOMX's Balance sheet
Foamix Pharmaceuticals Ltd's IV. Quarter Income $ 38 Millions Quarterly FOMX's Income Statement
FOMX's Income by Division See FOMX's Income by Division


FOMX Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 52 93 70 130 101
Y / Y Investment Growth -44.2 % 33.49 % -46.46 % 28.89 % 106.48 %
Net Income in Millions 95 74 66 29 17
Y / Y Net Income Growth 28.34 % 12.86 % 124.01 % 77.61 % 43.83 %
Annual Return On Investment 183.62 % 79.83 % 94.43 % 22.57 % 16.38 %


Annual Roi Comment
In the fiscal year 2019 ROI improved to 183.62 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Legal Cannabis Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
FOMX's Roi Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FOMX's Competitors
Subscribers only: Roi for Foamix Pharmaceuticals Ltd's Suppliers
Subscribers only: Return On Investment for FOMX's Customers

Other Ratios
FOMX's Roa FOMX's Inventory Turnover Ratio FOMX's Growth Rates FOMX's Dividend Statistics
FOMX's Profitability Ratios FOMX's Asset Turnover Ratio FOMX's Dividend Growth
FOMX's Roe FOMX's Valuation Ratios FOMX's Financial Strength Ratios FOMX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Consumer Non Cyclical Sector ROI
Cronos Group Inc   208.32 %
Stryve Foods Inc   158.87 %
Foamix Pharmaceuticals Ltd   145.14 %
Fitlife Brands Inc   80.08 %
Medifast Inc   60.69 %
Eos Inc   57.85 %
Hanjiao Group Inc   51.16 %
United guardian Inc   41.10 %
Philip Morris International Inc   31.81 %
The Davey Tree Expert Company  31.00 %
National Beverage Corp   29.94 %

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.